| Title |
Subjective endpoints in clinical trials: the case for blinded independent central review
|
|---|---|
| Published in |
Open Access Journal of Clinical Trials, September 2013
|
| DOI | 10.2147/oajct.s50283 |
| Authors |
Richard C Walovitch, Bin Yao, Patrick Chokron, Helen Le, Bubley |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 9% |
| Unknown | 10 | 91% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 4 | 36% |
| Professor | 2 | 18% |
| Unspecified | 1 | 9% |
| Other | 1 | 9% |
| Student > Doctoral Student | 1 | 9% |
| Other | 2 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 55% |
| Unspecified | 1 | 9% |
| Linguistics | 1 | 9% |
| Business, Management and Accounting | 1 | 9% |
| Agricultural and Biological Sciences | 1 | 9% |
| Other | 1 | 9% |